Targeting a key gene before birth could someday help lead to a treatment for Down syndrome by reversing abnormal embryonic brain development and improving cognitive function after birth, according to a Rutgers-led study by researchers at Rutgers-New Brunswick and Rutgers Robert Wood Johnson Medical School.
- A Decade of Progress: Addressing Humanity’s Shared Challenges.
- NJACTS Community Engagement Core Available Services
- Remote work has been a boon for people with disabilities. Will employers keep it going?
- Marijuana Component Offers Opioid Alternative by Effectively Treating Dental Pain.
- Join NJ ACTS Special Populations Core Seminar on December 5th at 12pm